I, G., E, C., M, C., A, G., D, P., A, C., . . . R, A. (2026). Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1.
Citación estilo ChicagoI, González-Martínez, et al. Enhanced Muscle Uptake of Chemically Optimized MiR-23b Antisense Oligonucleotides As Lead Compounds for Myotonic Dystrophy Type 1. 2026.
Cita MLAI, González-Martínez, et al. Enhanced Muscle Uptake of Chemically Optimized MiR-23b Antisense Oligonucleotides As Lead Compounds for Myotonic Dystrophy Type 1. 2026.
Precaución: Estas citas no son 100% exactas.